James Rolke — Chief Scientific Officer at La Jolla Pharmaceutical Company

Mr. James M. Rolke has been the Chief Scientific Officer of at La Jolla Pharmaceutical Co. since January 20, 2017. Mr. Rolke served as the Chief Technical Officer at Pluromed, Inc. Mr. Rolke served as Vice President of Research and Development at La Jolla Pharmaceutical Co. since January 2012 until January 20, 2017 and served as its Senior Director of Research and Development. Mr. Rolke has over 20 years of experience in medical device and pharmaceutical product development. He served leadership positions in several early stage companies including Prospect Therapeutics, Mersana Therapeutics and Surgical Sealants, Inc. He served as Director of Operations at Prospect Therapeutics, Inc., Associate Director of Pharmaceutical Development at Mersana Therapeutics, Inc., Manager of Process Development at GlycoGenesys, Inc., Principal Scientist at Surgical Sealants, Inc., Scientist at GelTex, Inc. and Associate Scientist at Alpha-Beta Technology, Inc. He holds a Bachelor of Science in Chemistry from Keene State College.